TNF-α and IL-6 were found to be significantly elevated in postmortem HD patient samples and in mouse models of HD (Bjorkqvist et al., 2008), and thus, boosting TIMP-2 levels in the HD brain could attenuate the neuroinflammatory response, thus providing therapeutic benefit. Here, IL6 is linked to Huntington disease.